Enas M. Hefzy

825 total citations
29 papers, 493 citations indexed

About

Enas M. Hefzy is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Enas M. Hefzy has authored 29 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Infectious Diseases and 6 papers in Epidemiology. Recurrent topics in Enas M. Hefzy's work include Antibiotic Resistance in Bacteria (6 papers), Bacterial biofilms and quorum sensing (5 papers) and Cancer-related molecular mechanisms research (4 papers). Enas M. Hefzy is often cited by papers focused on Antibiotic Resistance in Bacteria (6 papers), Bacterial biofilms and quorum sensing (5 papers) and Cancer-related molecular mechanisms research (4 papers). Enas M. Hefzy collaborates with scholars based in Egypt, Saudi Arabia and United States. Enas M. Hefzy's co-authors include Wafaa Y. Abdel Wahed, Mona I. Ahmed, Mahmoud A.F. Khalil, Mahmoud A. F. Khalil, Rania H. Mahmoud, G. Hassan, Tarek I. Ahmed, Omayma O. Abdelaleem, Noha A. Hassuna and Olfat Shaker and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Enas M. Hefzy

27 papers receiving 488 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Enas M. Hefzy Egypt 10 161 97 87 74 72 29 493
Ashraf I. Khasawneh Jordan 10 177 1.1× 52 0.5× 97 1.1× 64 0.9× 36 0.5× 28 437
Wei Xin Khong Singapore 10 67 0.4× 137 1.4× 296 3.4× 143 1.9× 89 1.2× 17 711
Hamed Alzoubi Jordan 8 155 1.0× 71 0.7× 137 1.6× 91 1.2× 54 0.8× 26 425
Cecilia Li Australia 15 103 0.6× 73 0.8× 159 1.8× 27 0.4× 4 0.1× 33 536
Manoj Menon United States 14 78 0.5× 34 0.4× 53 0.6× 11 0.1× 7 0.1× 50 614
Davide Mangioni Italy 13 114 0.7× 56 0.6× 273 3.1× 68 0.9× 38 0.5× 32 614
Hai Thanh Le Vietnam 13 22 0.1× 96 1.0× 75 0.9× 14 0.2× 128 1.8× 27 543
Patrick Ayscue United States 15 30 0.2× 52 0.5× 330 3.8× 113 1.5× 16 0.2× 19 703
Giorgio Bozzi Italy 15 57 0.4× 87 0.9× 340 3.9× 40 0.5× 15 0.2× 40 613
Ndèye Aïssatou Lakhe Senegal 4 22 0.1× 48 0.5× 148 1.7× 61 0.8× 17 0.2× 30 317

Countries citing papers authored by Enas M. Hefzy

Since Specialization
Citations

This map shows the geographic impact of Enas M. Hefzy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enas M. Hefzy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enas M. Hefzy more than expected).

Fields of papers citing papers by Enas M. Hefzy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enas M. Hefzy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enas M. Hefzy. The network helps show where Enas M. Hefzy may publish in the future.

Co-authorship network of co-authors of Enas M. Hefzy

This figure shows the co-authorship network connecting the top 25 collaborators of Enas M. Hefzy. A scholar is included among the top collaborators of Enas M. Hefzy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enas M. Hefzy. Enas M. Hefzy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hefzy, Enas M., et al.. (2023). Antiseptics and mupirocin resistance in clinical, environmental, and colonizing coagulase negative Staphylococcus isolates. Antimicrobial Resistance and Infection Control. 12(1). 110–110. 6 indexed citations
3.
Hefzy, Enas M., et al.. (2023). Hypervirulent Klebsiella pneumoniae: Epidemiology, virulence factors, and antibiotic resistance. SHILAP Revista de lepidopterología. 7(1). 1857–1872. 4 indexed citations
5.
Hefzy, Enas M., et al.. (2021). Bacteriocin-Like Inhibitory Substances from Probiotics as Therapeutic Agents for Candida Vulvovaginitis. Antibiotics. 10(3). 306–306. 23 indexed citations
7.
Mahmoud, Rania H., Enas M. Hefzy, Olfat Shaker, et al.. (2021). GAS5 rs2067079 and miR-137 rs1625579 functional SNPs and risk of chronic hepatitis B virus infection among Egyptian patients. Scientific Reports. 11(1). 20014–20014. 3 indexed citations
8.
Khalil, Mahmoud A.F., Mona I. Ahmed, Saad Alghamdi, et al.. (2021). Virulence Characteristics of Biofilm-Forming Acinetobacter baumannii in Clinical Isolates Using a Galleria mellonella Model. Microorganisms. 9(11). 2365–2365. 35 indexed citations
11.
Hefzy, Enas M., et al.. (2020). Analysis of the expression profile of long non‐coding RNAs MALAT1 and THRIL in children with immune thrombocytopenia. IUBMB Life. 72(9). 1941–1950. 16 indexed citations
12.
Wahed, Wafaa Y. Abdel, et al.. (2020). Assessment of Knowledge, Attitudes, and Perception of Health Care Workers Regarding COVID-19, A Cross-Sectional Study from Egypt. Journal of Community Health. 45(6). 1242–1251. 213 indexed citations
13.
Shaker, Olfat, et al.. (2019). Expression Profile of Long Noncoding RNAs, lnc-Cox2, and HOTAIR in Rheumatoid Arthritis Patients. Journal of Interferon & Cytokine Research. 39(3). 174–180. 36 indexed citations
14.
Hassuna, Noha A., et al.. (2019). Chronic Hepatitis C Infection Has No Effect on Peripheral CD4+CD25+ Tregulatory Cells in Patients with End-Stage Renal Disease. Immunological Investigations. 49(4). 477–488.
15.
Khalil, Mahmoud A.F., et al.. (2019). A Study of the Virulence Traits of Carbapenem-Resistant Klebsiella pneumoniae Isolates in a Galleria mellonella Model. Microbial Drug Resistance. 25(7). 1063–1071. 19 indexed citations
16.
Sabry, Dina, et al.. (2018). Interplay Between Helicobacter pylori Infection, Interleukin-11, and Leukemia Inhibitory Factor in Gastric Cancer Among Egyptian Patients. Journal of Interferon & Cytokine Research. 38(11). 517–525. 9 indexed citations
17.
Hefzy, Enas M., et al.. (2017). Evaluation of the correlation between insulin like factor 3, polycystic ovary syndrome, and ovarian maldescent. Gynecological Endocrinology. 34(6). 481–488. 8 indexed citations
18.
Hefzy, Enas M. & Noha A. Hassuna. (2016). Fluoroquinolone-Resistant Sequence Type 131 Subgroups O25b and O16 Among Extraintestinal Escherichia coli Isolates from Community-Acquired Urinary Tract Infections. Microbial Drug Resistance. 23(2). 224–229. 9 indexed citations
19.
20.
Hefzy, Enas M., et al.. (2015). Hospital outpatient clinics as a potential hazard for healthcare associated infections. Journal of Infection and Public Health. 9(1). 88–97. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026